About the Department

Clinical Services

Research

Education & Training

Quick Referral

Private Services

Make a Donation

Newsroom

For Professionals

Addiction Institute

Child & Family Institute

Women's Health Project

Resources

Videos

|
. |
|
Clinicians in the Department of Psychiatry and Behavioral Health at St. Luke's and Roosevelt Hospitals are actively engaged in a variety of clinical research projects targeting mental health, substance abuse, and other behavioral health
problems. Many of these research studies are funded by the National Institutes of Health (NIH), other federal agencies, or pharmaceutical companies and thus are able to offer patients free or limited-fee care for specific problems in exchange for their research participation. Because research projects are time-limited, available studies will vary depending on when a patient wants to participate. Also, as each study has specific rules about who can or cannot participate, even patients who want to enroll may not be able to participate. Therefore, it is important for patients to check the website to determine if any studies they are interested in and likely would qualify for are either active or soon will begin. Examples of the kind of studies our clinicians are conducting include those for depression, anxiety, post-traumatic stress disorder (PTSD), attention-deficit hyperactivity disorder (ADHD), alcoholism, "Crystal Meth", heroin abuse in teens, and drug abuse in medical patients with chronic pain or who require
an organ transplant.
As most of our research studies are "clinical" studies, treatment is often available to patients who choose to enroll. This includes new or state-of-the-art interventions that are still being tested as well as established treatments that are being tried in new populations. Before a patient enrolls in a research project, a staff member will review the study's goals, the pros and cons of participating, and the burden associated with being a participant (such as time commitment). All participants must sign an "informed consent form" prior to beginning the study. It is important to recognize that participation in a research study is strictly voluntary and failure to participate will not affect a patient's routine medical care; however, some treatments may not be available other than through the research study.
Because the treatments are being delivered within the context of research projects, patients may be "randomly assigned" to various treatment options. This means they may or may not get the treatment of their choice. In addition, participants in clinical trials often are required to provide information to the researchers on a regular basis by completing questionnaires or giving blood or urine samples. Patients may or may not be compensated for the time they spend completing research measures and providing samples.
Depending on the study selected, the research team will vary. However, all research projects have a Principal Investigator (PI) who is responsible for the project and many also have a research coordinator, research assistant, study physician, study nurse, and/or study therapists. Treatment personnel are licensed medical and mental health professionals who have special training in the research treatments and advanced trainees who are working alongside and are supervised by the research faculty.
While the various research projects are located throughout St. Luke's and Roosevelt Hospitals as well as in the community, the administrative offices of the Division of Clinical Research are located at St. Luke's Hospital in the Behavioral Science Research Unit (BSRU). A Research Administrative Assistant is available to take calls, answer questions, and direct patients to studies from 9 am to 5 pm, Monday to Friday. Please contact us at (212) 523-5232.
| TITLE |
FUNDING SOURCE |
PI |
| CTN0028
"Randomized Clinical Trial of Osmotic-Release Methylphenidate
for ADHD in Adolescents with Substance Use Disorders" (CTN 0028;
Fresh Focus) |
National Institute of Drug Abuse,
Clinical Trials Network/RFMH (subcontract) |
Michelle Acosta, PhD |
| CTN030:
"A two-phase randomized controlled clinical trial of buprenorphine/
naloxone treatment plus standard medical management or enhanced medical
management for opioid analgesic dependence" (CTN 0030; POATS) |
National Institute of Drug Abuse,
Clinical Trials Network/RFMH (subcontract) |
Deborah Haller, PhD |
| Drug
Treatment for Liver Transplant Candidates (TAP) |
National Institute of Drug Abuse |
Deborah Haller, PhD |
| MRI
of Infants Exposed Prenatally to Drugs of Abuse (Babies Study) |
National Institute of Drug Abuse |
Deborah Haller, PhD |
| Crystal
Clear Evaluation Project |
New York City Department of Health |
Deborah Haller, PhD |
| Combined
Treatment of Alcohol Dependent Women with PTSD (SAFE STEPS) |
National Institute on Alcoholism
and Alcohol Abuse/Columbia University School of Social Work (subcontract) |
Denise Hien, PhD |
| Science-Based
Treatment for Opioid-Dependent Adolescents |
National Institute on Drug Abuse |
Lisa Marsch, PhD |
| Computer-Assisted
HIV Prevention for Young Drug Users |
National Institute of Drug Abuse |
Lisa Marsch, PhD |
| The
Use of Acamprosate in Alcohol Dependent Individuals with Co-morbid
Anxiety and Depressive Disorders |
Forest Research Institute |
Richard N. Rosenthal, MD |
| Adolescent
Screening, Assessment, and Treatment (ASAT) |
Center for Substance Abuse Treatment
(CSAT)/Substance Abuse and Mental Health Services Administration (SAMHSA) |
Philip Clemmey, MD |
| PRO-808:
An Open-Label, Multi-Center Study Of Probuphine® In Patients With
Opioid Dependence |
Titan Pharmaceuticals, Inc
|
Richard N. Rosenthal, MD |
| Brief
Motivational Intervention during Hospital Admission to Promote Attendance
to Smoking Cessation Programs after Cardiac or Pulmonary Care (NIDA
2P50 DA09236-12 entitled “Novel Medication Approaches For Substance
Abuse” PI: Herbert D. Kleber, M.D.). |
NIDA
|
Deborah L. Haller, Ph.D.
Site PI: Angela R. Bethea, Ph.D. |
| Client
Centered Intervention To Increase Treatment Adherence In Patients
With Mental Illness |
|
Susan Tross PhD, Robin Kerner
PhD |
|
. |